Roche Holding Ltd. (NASDAQ:RHHBY) has been given a $38.00 price objective by analysts at Cowen and Company in a report released on Monday. The firm currently has a “buy” rating on the stock. Cowen and Company’s price objective points to a potential upside of 20.71% from the stock’s previous close.

Several other research analysts have also issued reports on the company. Zacks Investment Research lowered Roche Holding from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, May 9th. Deutsche Bank AG lowered Roche Holding from a “buy” rating to a “hold” rating in a research report on Friday, July 7th. BNP Paribas reaffirmed a “neutral” rating on shares of Roche Holding in a research report on Tuesday, June 20th. Morgan Stanley reaffirmed an “equal weight” rating on shares of Roche Holding in a research report on Wednesday, July 26th. Finally, Societe Generale lowered Roche Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 30th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $37.00.

Roche Holding (RHHBY) remained flat at $31.48 during midday trading on Monday. The stock had a trading volume of 546,080 shares. The company’s 50 day moving average price is $31.83 and its 200-day moving average price is $31.96. Roche Holding has a 52-week low of $25.25 and a 52-week high of $36.82. The firm has a market capitalization of $214.89 billion and a price-to-earnings ratio of 21.59.

WARNING: This report was originally reported by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this report can be read at https://www.americanbankingnews.com/2017/08/14/roche-holding-ltd-nasdaqrhhby-earns-buy-rating-from-cowen-and-company.html.

Several hedge funds and other institutional investors have recently bought and sold shares of RHHBY. Parametric Portfolio Associates LLC raised its position in Roche Holding by 20.4% in the first quarter. Parametric Portfolio Associates LLC now owns 3,251,825 shares of the company’s stock valued at $104,156,000 after buying an additional 550,838 shares during the period. Moody Lynn & Lieberson LLC acquired a new position in Roche Holding during the first quarter valued at $11,158,000. Capital Counsel LLC NY raised its position in Roche Holding by 30.5% in the second quarter. Capital Counsel LLC NY now owns 1,428,387 shares of the company’s stock valued at $45,423,000 after buying an additional 334,008 shares during the period. Bristol John W & Co. Inc. NY raised its position in Roche Holding by 13.1% in the second quarter. Bristol John W & Co. Inc. NY now owns 2,327,621 shares of the company’s stock valued at $74,193,000 after buying an additional 269,099 shares during the period. Finally, Schafer Cullen Capital Management Inc. raised its position in Roche Holding by 10.8% in the first quarter. Schafer Cullen Capital Management Inc. now owns 2,369,119 shares of the company’s stock valued at $75,883,000 after buying an additional 230,620 shares during the period.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (NASDAQ:RHHBY)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.